With the aid of CRISPR gene editing techniques, researchers have identified a new biomarker for Alzheimer's disease. The study reports a deficiency of the protein STIM1 could be implicated in the sporadic version of the neurodegenerative disease.
|
Tuesday, October 09, 2018
STIM1
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment